Alexion Pharmaceuticals Acquires Enobia Pharma for $1,080,000,000
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b8f877e7-cbd0-4f56-bf35-3c8c854e8dbf&Preview=1 -
Date
12/29/2011 -
Company Name
Enobia Pharma -
Mailing Address
55 Cambridge Parkway Cambridge, MA 02142 -
Company Description
Enobia Pharma is a developer of enzyme replacement therapies for the treatment of serious bone diseases. -
Website
http://www.enobia.com -
Transaction Type
M&A -
Transaction Amount
$1,080,000,000 -
Transaction Round
-
Proceeds Purposes
-
M&A Terms
Alexion has agreed to pay $610 million in cash upon consummation of the transaction, and up to $470 million in cash to be paid upon achievement of various regulatory and sales milestones. Alexion is not issuing equity in connection with the acquisition.
